Pfizer Leans On Lipitor, Cost Cutting
Drugmaker doubles earnings in second quarter, beating estimates. 4 months ago
Forbes Click here to Read the Full StoryDrugmaker doubles earnings in second quarter, beating estimates. 4 months ago
Forbes Click here to Read the Full Story